You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

Hexamer Therapeutics announced it raised $500,000 in an initial filing from an offering of $2.5 Million

PRIVATESep 15, 2026•about 3 hours ago

Amount Raised

$500,000

Round Type

Seed

PullmanBiotechnology

Company Information

Company

Hexamer Therapeutics

Location

2345 NE HOPKINS CT

Pullman, Washington, United States

About

As innovators, we are focused on creating ways of solving health problems every single day.

Don't miss Hexamer Therapeutics's next move

Get an email the moment Hexamer Therapeutics raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Suggested for you

1 contact

Predictive Intelligence

Strategic

ML-powered predictions for Hexamer Therapeutics's next move

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Hexamer Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.